Cabot's top 10 trader and top pick

Investing.com
2024-12-30

Investing.com -- Cabot gave its weekly top ten stock list, naming Kyndryl Holdings (NYSE:KD) its top pick given its attractive entry point.

“As for the market, things finished up with a nice rally last Friday, but while certainly good to see, that doesn’t undo the action of the prior couple of weeks as a whole,” analyst wrote highlighting that many major indexes and growth measures had cracked their intermediate-term uptrends.

Astera Labs: Riding the AI wave with its cutting-edge PCIe 6 switches, Astera is primed to dominate high-speed data transfer in cloud-scale environments.

Birkenstock (NYSE:BIRK): The sandal giant leverages its luxury scarcity model and quality-focused manufacturing to drive robust sales growth.

Celestica (NYSE:CLS): Positioned as a key enabler in the AI ecosystem, Celestica thrives with its high-speed ethernet switches and optical transceivers.

Dutch Bros: A rapid expansion strategy and innovative menu offerings have turned Dutch Bros into a promising growth story.

Klaviyo (NYSE:KVYO): Simplifying marketing for retailers, Klaviyo’s user-friendly platform integrates customer data for optimized campaigns.

Kyndryl Holdings: A former IBM (NYSE:IBM) division, Kyndryl leverages AI and cloud trends to modernize hybrid IT systems with strong consulting growth.

Ollie’s Bargain Outlet: With its strategic acquisitions and closeout retail model, Ollie’s is scaling operations while maintaining financial stability.

Taiwan Semiconductor: The chipmaking powerhouse continues to lead with advanced semiconductor production and expansion into global markets.

Trip.com: As Chinese travel rebounds, Trip.com is exceeding pre-pandemic levels, driven by strong domestic and international demand.

United Airlines: Optimized operations and increased travel demand position United Airlines for sustained profitability and growth in 2025.

Related Articles

Cabot's top 10 trader and top pick

Father of woman killed in South Korea air crash says the tragedy is unbelievable

Roche has no plans for job cuts and business is healthy, CEO says

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10